Mahadevia Ankit - Insider Non-Derivative Transactions at Spero Therapeutics, Inc. (SPRO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 27, 2024, Mahadevia Ankit's relationship to Spero Therapeutics, Inc. (SPRO) is Director, and currently has 759,085 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SPRO insiders.
Data Source: SEC.
Mahadevia Ankit - Insider Non-Derivative Transactions of SPRO Common Stock
Mahadevia Ankit - Insider Non-Derivative Transactions at SPRO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 28, 2024 | Sell -- (Common Stock) | 5912 | 1.35 | 759085 |
| May 30, 2024 | Acquisition -- (Common Stock) | 20000 | 0 | 764997 |
| Feb 3, 2024 | Sell -- (Common Stock) | 63795 | 1.37 | 744997 |
| Oct 6, 2023 | Acquisition -- (Common Stock) | 20000 | 0 | 808792 |
| Aug 29, 2023 | Sell -- (Common Stock) | 9040 | 1.26 | 788792 |
| Feb 4, 2023 | Sell -- (Common Stock) | 12286 | 1.81 | 797832 |
| Feb 2, 2023 | Acquisition -- (Common Stock) | 531914 | 0 | 810118 |